Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedariston vs Placebo in Children and Adolescents with ADHD
NCT00782080Phase 3Completed
- Start
- Jul 2008
- Primary completion
- Mar 2010
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Sedariston with Placebo (2 arms). Primary endpoint: ADHD-IV Rating Scale Total Score at 8 weeks. Started Jul 2008; status: completed.
02
Drugs
Sedariston
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00782080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782080.